Efficacy of Intensity Modulated Radiation Therapy After Surgery in Early Stage of Esophageal Carcinoma;

NCT01745107 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2019-01-31

No results posted yet for this study

Summary

The purpose of this study is to determine the efficacy of preventive intensity modulated radiation therapy after surgery in stage T2-3N0M0 disease of thoracic esophageal squamous cell carcinoma(UICC 7th edition) and to identify the subgroup benefiting from the treatment.

Conditions

  • Esophageal Neoplasm
  • Esophageal Cancer TNM Staging Primary Tumor (T) T2
  • Esophageal Cancer TNM Staging Primary Tumor (T) T3
  • Esophageal Cancer TNM Staging Regional Lymph Nodes (N) N0
  • Esophageal Cancer TNM Staging Distal Metastasis (M) M0

Interventions

RADIATION

Prophylactic postoperative radiation therapy

Prescription dose of 95%planning target volume(PTV) 50.4Gy/1.8Gy/28fractions for supraclavicular region and 95%PTV 56Gy/2Gy/28fractions for mediastinum which is delivered in 2 months after surgery.

Sponsors & Collaborators

  • Sichuan Cancer Hospital and Research Institute

    collaborator OTHER
  • Tianjin Medical University Cancer Institute and Hospital

    collaborator OTHER
  • Chinese Academy of Medical Sciences

    lead OTHER

Principal Investigators

  • Zefen Xiao, MD · The Department of Radiation Oncology ,Cancer Institute & Hospital,Chinese Academy of Medical Science

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
72 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2018-12-31
Completion
2021-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01745107 on ClinicalTrials.gov